DK1451224T3 - Peptid eller protein, der indeholder en C´-D-sløjfe fra CD28-receptorfamilien - Google Patents

Peptid eller protein, der indeholder en C´-D-sløjfe fra CD28-receptorfamilien

Info

Publication number
DK1451224T3
DK1451224T3 DK02804143.2T DK02804143T DK1451224T3 DK 1451224 T3 DK1451224 T3 DK 1451224T3 DK 02804143 T DK02804143 T DK 02804143T DK 1451224 T3 DK1451224 T3 DK 1451224T3
Authority
DK
Denmark
Prior art keywords
peptide
loop
protein containing
receptor family
receptor
Prior art date
Application number
DK02804143.2T
Other languages
English (en)
Inventor
Thomas Huenig
Fred Luehder
Thomas Hanke
Original Assignee
Theramab Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2001160516 external-priority patent/DE10160516A1/de
Application filed by Theramab Llc filed Critical Theramab Llc
Application granted granted Critical
Publication of DK1451224T3 publication Critical patent/DK1451224T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70521—CD28, CD152
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK02804143.2T 2001-12-04 2002-10-29 Peptid eller protein, der indeholder en C´-D-sløjfe fra CD28-receptorfamilien DK1451224T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE2001160516 DE10160516A1 (de) 2001-12-04 2001-12-04 Peptid oder Protein enthaltend ein C'-D Loop der CD28 Rezeptorfamilie
DE10200714 2002-01-10
PCT/DE2002/004064 WO2003048194A2 (de) 2001-12-04 2002-10-29 Peptid oder protein enthaltend ein c'-d loop der cd28 rezeptorfamilie

Publications (1)

Publication Number Publication Date
DK1451224T3 true DK1451224T3 (da) 2012-11-19

Family

ID=26010744

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02804143.2T DK1451224T3 (da) 2001-12-04 2002-10-29 Peptid eller protein, der indeholder en C´-D-sløjfe fra CD28-receptorfamilien

Country Status (7)

Country Link
US (3) US20030166860A1 (da)
EP (1) EP1451224B1 (da)
AU (1) AU2002357427A1 (da)
DK (1) DK1451224T3 (da)
ES (1) ES2392287T3 (da)
PT (1) PT1451224E (da)
WO (1) WO2003048194A2 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10212108A1 (de) * 2002-03-13 2003-10-02 Tegenero Ag Verwendung einer an CD28 bindenden Wirksubstanz zur Herstellung einer pharmazeutischen Zusammensetzung
EP1460088A1 (en) * 2003-03-21 2004-09-22 Biotest AG Humanized anti-CD4 antibody with immunosuppressive properties
EP1600164A3 (de) * 2003-09-22 2006-05-17 TeGenero AG Verwendung einer an CD28 bindenden Wirksubstanz zur Herstellung einer Pharmazeutischen Zusammensetzung mit dosisabhängiger Wirkung
DE10352900A1 (de) * 2003-11-11 2005-06-16 Tegenero Ag Verwendung einer an CD28 bindenden Wirksubstanz zur Herstellung einer pharmazeutischen Zusammensetzung zur Behandlung von B-CLL
GB0400440D0 (en) * 2004-01-09 2004-02-11 Isis Innovation Receptor modulators
PT2171060E (pt) * 2004-11-11 2013-11-18 Theramab Llc Anticorpo anti-cd28 superagonista
US7585960B2 (en) 2005-05-11 2009-09-08 Theramab Gmbh Nucleic acids encoding superagonistic anti-CD28 antibodies
RU2540013C2 (ru) * 2008-03-13 2015-01-27 Биотест Аг Средство для лечения заболевания
EP2260057B1 (en) * 2008-03-13 2016-11-23 Biotest AG Anti-CD4 antibody dosage regimen for treating autoimmune disease
EP2265643B1 (en) * 2008-03-13 2016-10-19 Biotest AG Dosing regimen for treating psoriasis and rheumatoid arthritis
BRPI0919489A2 (pt) * 2008-09-29 2015-12-01 Biotest Ag composição, kit, métodos de tratamento de uma doença reumática, e de artrite reumatóide em um paciente, agente capaz de ativar células t reguladoras cd4+cd25+ e metotrexato, e, uso de um agente capaz de ativar células t reguladoras cd4+cd25+ e metotrexato
GB0920944D0 (en) 2009-11-30 2010-01-13 Biotest Ag Agents for treating disease
US8907053B2 (en) * 2010-06-25 2014-12-09 Aurigene Discovery Technologies Limited Immunosuppression modulating compounds
CA2868408A1 (en) * 2012-03-29 2013-10-03 Aurigene Discovery Technologies Limited Immunomodulating cyclic compounds from the bc loop of human pd1
EP2886645A1 (en) * 2013-12-20 2015-06-24 Julius-Maximilians-Universität Würzburg Expansion of human T cells in vitro by bead-bound conventional anti-CD28 monoclonal antibodies
MA41414A (fr) 2015-01-28 2017-12-05 Centre Nat Rech Scient Protéines de liaison agonistes d' icos
WO2017079656A2 (en) * 2015-11-04 2017-05-11 The Trustees Of The University Of Pennsylvania Artificial proteins and compositions and methods thereof
EP3436480A4 (en) * 2016-03-30 2019-11-27 Musc Foundation for Research Development METHOD FOR THE TREATMENT AND DIAGNOSIS OF CANCER BY TARGETING GLYCOPROTEIN A REPETITION PREDOMINANT (GARP) AND FOR EFFECTIVE IMMUNOTHERAPY ALONE OR IN COMBINATION
CA3192204A1 (en) 2020-08-19 2022-02-24 Xencor, Inc. Anti-cd28 and/or anti-b7h3 compositions
US12365743B2 (en) 2022-02-23 2025-07-22 Xencor, Inc. Anti-CD28 x anti-PSMA antibodies

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6641809B1 (en) * 1990-03-26 2003-11-04 Bristol-Myers Squibb Company Method of regulating cellular processes mediated by B7 and CD28
US6090914A (en) * 1991-06-27 2000-07-18 Bristol-Myers Squibb Company CTLA4/CD28Ig hybrid fusion proteins and uses thereof
DE19722888A1 (de) 1997-05-28 1998-12-03 Thomas Prof Dr Huenig Human-CD28 spezifische monoklonale Antikörper zur antigenunspezifischen Aktivierung von T-Lymphozyten
EP0947582A1 (en) * 1998-03-31 1999-10-06 Innogenetics N.V. A polypeptide structure for use as a scaffold
AU2001245945A1 (en) * 2000-03-23 2001-10-03 Pe Corporation (Ny) Detection kits, such as nucleic acid arrays, for detecting the expression of 10,000 or more drosophila genes and uses thereof

Also Published As

Publication number Publication date
WO2003048194A3 (de) 2004-02-26
WO2003048194A2 (de) 2003-06-12
US20030166860A1 (en) 2003-09-04
AU2002357427A1 (en) 2003-06-17
EP1451224B1 (de) 2012-08-15
EP1451224A2 (de) 2004-09-01
PT1451224E (pt) 2012-10-09
US20110052587A1 (en) 2011-03-03
US8586386B2 (en) 2013-11-19
AU2002357427A8 (en) 2003-06-17
US20070031407A1 (en) 2007-02-08
ES2392287T3 (es) 2012-12-07

Similar Documents

Publication Publication Date Title
DK1451224T3 (da) Peptid eller protein, der indeholder en C´-D-sløjfe fra CD28-receptorfamilien
DE50212615D1 (de) Lyophilisierte zubereitung enthaltend antikörper gegen den egf-rezeptor
NO20002800D0 (no) Cyklosporinholdig mikroemulsjon, forkonsentratsammensetning
ATE464322T1 (de) Antikörper gegen den rezeptor für den insulinähnlichen wachstumsfaktor i
IL160181A0 (en) N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands
EP1401476A4 (en) IGF-ANTAGONISTS PEPTIDES
DE69938174D1 (de) Peptid zusammensetzungen und formulierungen unter verwendung derselben
ATE333449T1 (de) 1,2,4-thiadiazoliumverbindungen als melanocortinrezeptor-modulatoren
DK1179014T3 (da) Derivater af Z-domænet fra staphylococcalt protein A (SPA), som interagerer med mindst ét domæne fra human faktor VIII
CY1107339T1 (el) Mu-1, μελος της οικογενειας υποδοχεα κυτοκινης
PT2341141E (pt) Proteína vi recetora de colagénio plaquetário recombinante, anticorpos e seus usos
NO20025114L (no) Trombopoitein-reseptormodulerende peptid
EP1023437A4 (en) Receptor Kinase, BIN1
DE69835433D1 (de) Disulfid-vernetzte glycoprotein-hormone, ihre herstellung und verwendung
EP1406493A4 (en) ADMINISTRATION OF MEDIUM BY THE PEPT-2 TRANSPORTER
EP1088831A4 (en) HEMOPOIETIN RECEPTOR PROTEINS
IT1303546B1 (it) Cerniera lampo.
IL145848A0 (en) Peptides from the tt virus sequence and monospecific antibodies binding to the tt virus
FR2791348B1 (fr) POLYPEPTIDE Npt2B
EP1253928A4 (en) NEW HAPTOTACTIC PEPTIDES
GB0030309D0 (en) Antibodies,Peptides,Analogs and uses thereof
FR2793467B1 (fr) Systeme d'attache au sol d'un dirigeable
AU3327600A (en) Novel guanosine triphosphate (gtp)-binding protein-coupled receptor proteins, bg3
ZA981891B (en) Peptides useful as somatostatin antagonists.
ITCO20000026A1 (it) A2 s.p.r. scuotitore prenditore raccoglitore per l'olive